Publication:
A MUTATION OF ASPARTOACYLASE GENE IN A TURKISH PATIENT WITH CANAVAN DISEASE

dc.contributor.authorGungor, H. Eke
dc.contributor.authorIscan, AKIN
dc.contributor.authorCece, H.
dc.contributor.authorCalik, M.
dc.contributor.institutionauthorİŞCAN, AKIN
dc.date.accessioned2020-10-29T14:07:18Z
dc.date.available2020-10-29T14:07:18Z
dc.date.issued2012-01-01T00:00:00Z
dc.description.abstractA mutation of aspartoacylase gene in a Turkish patient with Canavan disease: Canavan disease (CD) is an autosomal recessive inherited disorder characterized by spongy degeneration of the brain. The deficiency of aspartoacylase (ASPA), resulting in the accumulation of N-acetyl aspartic acid (NAA) in the brain, plays an important role in the pathogenesis of the disease. The cardinal features of this neurodegenerative disease are macrocephaly, mental retardation, and hypotonia. Magnetic resonance imaging (MRI) of the brain generally shows diffuse white matter degeneration and also elevated excretion of urinary NAA is usually seen. A large number of mutations were identified to date. We report here a 9 months old girl with Canavan Disease and a homozygous c.79G>A mutation in the ASPA gene, detected for the first time in Turkish population.
dc.identifier.citationGungor H. E. , Iscan A., Cece H., Calik M., -A MUTATION OF ASPARTOACYLASE GENE IN A TURKISH PATIENT WITH CANAVAN DISEASE-, GENETIC COUNSELING, cilt.23, ss.9-12, 2012
dc.identifier.scopus84860273466
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25254
dc.identifier.wosWOS:000303033000002
dc.titleA MUTATION OF ASPARTOACYLASE GENE IN A TURKISH PATIENT WITH CANAVAN DISEASE
dc.typeArticle
dspace.entity.typePublication
local.avesis.id1cc031ab-0573-4d02-9184-6f3e7ae522f5
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication12538a20-d5a6-4246-ab37-58afe7bbae72
relation.isAuthorOfPublication.latestForDiscovery12538a20-d5a6-4246-ab37-58afe7bbae72

Files